Furosemide
- Product NDC
- 68071-2313
- 11-digit product format
- 680712313
- Labeler code
- 68071
- Product ID
- 68071-2313_d775c43c-2c40-586b-e053-2a95a90a0b35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- furosemide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA076796
- Marketing category
- ANDA
- Marketing start
- 2004-03-26
- Marketing end
- 0000-00-00
- Substance
- FUROSEMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68071-2313 | I | Inactivated by FDA | 2026-08-10 | ||
| excluded package | package | 68071-2313 | 68071-2313-3 | I | Inactivated by FDA | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68071-2313-3 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68071-2313-3 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68071-2313-3 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68071-2313-3 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076796-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | |
| A076796-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | |
| A076796-003 | FUROSEMIDE | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076796-001 | AB |
| A076796-002 | AB |
| A076796-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-002 | FUROSEMIDE | 40MG | TABLET / ORAL | AB | 2004-03-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-003 | FUROSEMIDE | 80MG | TABLET / ORAL | AB | 2004-03-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A076796-001 | FUROSEMIDE | 20MG | TABLET / ORAL | AB | 2004-03-26 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A076796-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076796-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076796-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076796-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076796-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076796-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076796-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076796-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076796-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076796-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076796-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A076796-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076796-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076796-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076796-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A076796-001 | AB | 1 | 8072bd15b7f6… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d80d3aff-3a63-4d7b-a2be-fd9388b04330 | Product name | 9 | 20250806 |
| 9061e89f-9c86-4196-b34b-886fc1673cc4 | Product name | 1 | 20140821 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2313-3 | 2025-01-30 | C162847 | 48780-1 | d6a99b3a-010a-a426-e053-dadaa90af4c2 | FUROSEMIDE TABLETS, USP 20, 40, and 80 mg |
| 68071-2313-3 | 2022-02-07 | C162847 | 48780-1 | d6a99b3a-010a-a426-e053-dadaa90af4c2 | FUROSEMIDE TABLETS, USP 20, 40, and 80 mg |
| 68071-2313-3 | 2022-01-28 | C162847 | 48780-1 | d6a99b3a-010a-a426-e053-dadaa90af4c2 | FUROSEMIDE TABLETS, USP 20, 40, and 80 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2313-3 | Furosemide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2313 | FUROSEMIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 2 | Legacy NDC, 1 package rows | 20220208_b623c3b3-3e25-67f0-e053-2a95a90a297c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 3d312ab0-589c-427b-84da-18887244bfc9 | 2026-07-15 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | 2a5bcf50-6d63-463a-915e-a72ea2e5f131 | 2026-06-18 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Major Pharmaceuticals | 6be1addd-a811-47fc-8650-6870d661c234 | 2026-05-26 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | REMEDYREPACK INC. | 7181e528-c862-4dd7-8446-9011e4c7312a | 2026-04-23 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | bd45c963-a413-e9a1-e053-2a95a90a1438 | 2026-02-19 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | AvKARE | d4c532be-1f3f-60d3-e053-2995a90a98be | 2026-01-14 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | f2b920b2-f8b3-1e6e-e053-2a95a90ae153 | 2026-01-01 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2025-08-18 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2025-08-15 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2025-08-15 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2025-08-15 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 3ba730ab-90d4-478a-80b3-1ea3edb03e4d | 2025-07-15 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Solco Healthcare LLC | 6a0fb397-63ae-4fce-bddf-16a91b1b7a2f | 2025-06-18 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 114f4f4f-536a-4658-8fd0-2dd8c029b19a | 2024-09-17 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 25c0aded-ffcd-4145-a48c-76c5fb220f61 | 2024-08-23 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 6cbf3834-0433-4dc0-e053-2a91aa0a8f8a | 2024-06-10 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 7316929d-413a-e78f-e053-2a91aa0a417e | 2024-06-10 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals,Inc. | 73e5c8f3-32f8-114c-e053-2a91aa0ab500 | 2024-06-10 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 4b3e2e13-a657-4da5-b536-8ae0a26812e0 | 2024-06-03 | Warnings, Adverse reactions | 076796 ANDA076796 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 3b028a3c-102a-40f1-820e-b187ff1e1803 | 2024-03-22 | Warnings, Adverse reactions | 076796 ANDA076796 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310429 | furosemide 20 MG Oral Tablet | PSN | b623c3b3-3e25-67f0-e053-2a95a90a297c | 2 |
| 310429 | furosemide 20 MG Oral Tablet | SCD | b623c3b3-3e25-67f0-e053-2a95a90a297c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-2313-3 | 68071231303 | 30 TABLET in 1 BOTTLE, PLASTIC (68071-2313-3) | 30 tablet | 2020-12-10 | 0000-00-00 | No | No | Current |